dsip inject arm DSIP: The Sleep Peptide That Changes How Canadians Rest How do I do a

Pros of B12 Oral Sprays: Up to 90% absorption rate (comparable to injections) Completely painless and non-invasive No needles, no medical appointments Convenient daily use at home Travel-friendly and portable More affordable long-term Can use methylcobalamin (superior bioavailability) Pleasant taste (raspberry flavor) No risk of infection Cons of B12 Oral Sprays: Requires daily consistency Must hold under tongue for 30-60 seconds May not be suitable for extremely severe deficiency requiring immediate correction Absorption Comparison One of the biggest myths about B12 supplementation is that injections are the only way to achieve high absorption

The peptide not only accelerates healing but also enhances the strength and resilience of tissues as they recover

What the evidence supports: BPC-157 consistently improves tendon healing outcomes in animal models across multiple tissue types and injury models TB-500 accelerates wound healing and tissue repair in preclinical studies with measurable improvements in re-epithelialization, collagen deposition, and angiogenesis GHK-Cu enhances collagen synthesis and modulates thousands of genes involved in tissue repair GHRP-2 shifts macrophage polarization favorably in a rotator cuff tear model Relaxin-2 eliminates capsular fibrosis in a frozen shoulder mouse model No significant toxicity has been identified in preclinical BPC-157 studies What remains uncertain: Whether animal study results translate to equivalent human outcomes for shoulder conditions specifically Optimal dosing for human shoulder injuries (all protocols are extrapolated from animal data and clinical observation) Long-term safety with repeated use Whether peptides meaningfully reduce rotator cuff retear rates after surgical repair in humans How peptide therapy compares to established treatments like PRP in controlled human studies Potential interactions with medications commonly used by shoulder pain patients What we need: Randomized controlled trials of BPC-157 and TB-500 for specific shoulder conditions in humans Head-to-head comparisons of peptide therapy versus established treatments Long-term safety data from monitored human use Standardized dosing protocols based on human pharmacokinetic data Studies combining peptides with rehabilitation to assess synergistic effects The preclinical evidence is compelling

High-dose oral b12 protocols Oral b12 can overcome absorption issues through mass action

Therapy with the BPC-157 peptide is also part of this treatment